Legal & General Group PLC Scopus Bio Pharma Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$5.17 - $10.25 $2,796 - $5,545
-541 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.94 - $14.87 $4,295 - $8,044
541 New
541 $5,000

Others Institutions Holding SCPS

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About Scopus BioPharma Inc.

SCPS Quotes by TradingView
  • Ticker SCPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,094,300
  • Description
  • Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...
More about SCPS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email